Recently, New Hampshire State Representative Jim Kofalt wrote a piece for the RAIR Foundation USA, reporting that New Hampshire’s Department of Children, Youth and Families (DCYF) has made a move to separate a teenage boy from his father and mother because the former administered ivermectin to the young man to treat COVID-19.
How far will authorities go now to declare how people living in the United States will care for themselves and their family members? In New Hampshire, the Department of Children, Youth, and Families (DCYF) possesses considerable authority when it comes to matters of child neglect, abuse, and other relevant matters. But what about the case when an off-label treatment is used for a teenager in response to COVID-19?
In this case, a father had no ill intent and arguably there was little risk, depending on whether the ivermectin was prescribed by a licensed professional. Ivermectin is a safe treatment only known for mild side effects if any. Some could argue, as did Representative Kofalt, that many over-the-counter medications pose more danger than ivermectin used for COVID-19 indication. But what if it is used off-label? Obviously, if a licen...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).